Fiasp

Active Ingredient(s): Insulin Aspart
FDA Approved: * September 29, 2017
Pharm Company: * NOVO NORDISK INC
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Fiasp Overview

Insulin aspart, sold under the brand name Novolog among others, is a type of manufactured insulin used to treat type I and type II diabetes.[1] Typically it is taken just before eating.[1] It is generally used by injection under the skin but may also be used by injection into a vein.[1] Maximum effect occurs after about 2 hours and lasts for 4 hours.[1] Generally a longer-acting insulin like NPH is also needed.[1]...

Read more Fiasp Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Insulin_aspart

Recent Fiasp Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Insulin Aspart
  • Injection: 100 Units/ml, 100unit/ml
  • Solution: 1000 Units/10ml (100 Units/ml), 300 Units/3ml (100 Units/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Fiasp: (3 results)

Sorted by National Drug Code
  • 0169-3201 Fiasp 100 [Iu]/Ml Subcutaneous Injection, Solution by Novo Nordisk
  • 0169-3204 Fiasp 100 [Iu]/Ml Subcutaneous Injection, Solution by Novo Nordisk
  • 0169-3205 Fiasp 100 [Iu]/Ml Subcutaneous Injection, Solution by Novo Nordisk

Other drugs which contain Insulin Aspart or a similar ingredient: (6 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA